53 related articles for article (PubMed ID: 33106467)
21. Analysis of 59 cases of congenital leukemia reported between 2001 and 2016.
Zhang Q; Ren Z; Yang J; Yin A
J Int Med Res; 2019 Oct; 47(10):4625-4635. PubMed ID: 31558073
[TBL] [Abstract][Full Text] [Related]
22. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
[TBL] [Abstract][Full Text] [Related]
23. How I treat infant leukemia.
Brown P; Pieters R; Biondi A
Blood; 2019 Jan; 133(3):205-214. PubMed ID: 30459160
[TBL] [Abstract][Full Text] [Related]
24. Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Bhojwani D; Sposto R; Shah NN; Rodriguez V; Yuan C; Stetler-Stevenson M; O'Brien MM; McNeer JL; Quereshi A; Cabannes A; Schlegel P; Rossig C; Dalla-Pozza L; August K; Alexander S; Bourquin JP; Zwaan M; Raetz EA; Loh ML; Rheingold SR
Leukemia; 2019 Apr; 33(4):884-892. PubMed ID: 30267011
[TBL] [Abstract][Full Text] [Related]
25. Neonatal leukaemia.
Roberts I; Fordham NJ; Rao A; Bain BJ
Br J Haematol; 2018 Jul; 182(2):170-184. PubMed ID: 29806701
[TBL] [Abstract][Full Text] [Related]
26. Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
von Stackelberg A; Locatelli F; Zugmaier G; Handgretinger R; Trippett TM; Rizzari C; Bader P; O'Brien MM; Brethon B; Bhojwani D; Schlegel PG; Borkhardt A; Rheingold SR; Cooper TM; Zwaan CM; Barnette P; Messina C; Michel G; DuBois SG; Hu K; Zhu M; Whitlock JA; Gore L
J Clin Oncol; 2016 Dec; 34(36):4381-4389. PubMed ID: 27998223
[TBL] [Abstract][Full Text] [Related]
27. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
[TBL] [Abstract][Full Text] [Related]
28. Images in clinical medicine. Congenital cytomegalovirus infection.
Abdel-Latif Mel-A; Sugo E
N Engl J Med; 2010 Mar; 362(9):833. PubMed ID: 20200387
[No Abstract] [Full Text] [Related]
29. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
van der Linden MH; Valsecchi MG; De Lorenzo P; Möricke A; Janka G; Leblanc TM; Felice M; Biondi A; Campbell M; Hann I; Rubnitz JE; Stary J; Szczepanski T; Vora A; Ferster A; Hovi L; Silverman LB; Pieters R
Blood; 2009 Oct; 114(18):3764-8. PubMed ID: 19657114
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
[TBL] [Abstract][Full Text] [Related]
31. Features and outcome of neonatal leukemia in Japan: experience of the Japan infant leukemia study group.
Ishii E; Oda M; Kinugawa N; Oda T; Takimoto T; Suzuki N; Kosaka Y; Ohara A; Ogawa A; Ishii M; Sakata N; Okamura T; Koike K; Kojima S; Horibe K; Mizutani S
Pediatr Blood Cancer; 2006 Sep; 47(3):268-72. PubMed ID: 16333820
[TBL] [Abstract][Full Text] [Related]
32. Prenatal origin of acute lymphoblastic leukaemia in children.
Wiemels JL; Cazzaniga G; Daniotti M; Eden OB; Addison GM; Masera G; Saha V; Biondi A; Greaves MF
Lancet; 1999 Oct; 354(9189):1499-503. PubMed ID: 10551495
[TBL] [Abstract][Full Text] [Related]
33. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero.
Wiemels JL; Ford AM; Van Wering ER; Postma A; Greaves M
Blood; 1999 Aug; 94(3):1057-62. PubMed ID: 10419898
[TBL] [Abstract][Full Text] [Related]
34. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.
Gale KB; Ford AM; Repp R; Borkhardt A; Keller C; Eden OB; Greaves MF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13950-4. PubMed ID: 9391133
[TBL] [Abstract][Full Text] [Related]
35. In utero rearrangements in the trithorax-related oncogene in infant leukaemias.
Ford AM; Ridge SA; Cabrera ME; Mahmoud H; Steel CM; Chan LC; Greaves M
Nature; 1993 May; 363(6427):358-60. PubMed ID: 8497319
[TBL] [Abstract][Full Text] [Related]
36. Blueberry muffin baby: neonatal neuroblastoma with subcutaneous metastases.
Shown TE; Durfee MF
J Urol; 1970 Jul; 104(1):193-5. PubMed ID: 5426702
[No Abstract] [Full Text] [Related]
37. Dermal hematopoiesis in neonates: report of five cases.
Bowden JB; Hebert AA; Rapini RP
J Am Acad Dermatol; 1989 Jun; 20(6):1104-10. PubMed ID: 2546982
[TBL] [Abstract][Full Text] [Related]
38. US cancer incidence and mortality in the first year of life.
Bader JL; Miller RW
Am J Dis Child; 1979 Feb; 133(2):157-9. PubMed ID: 420185
[TBL] [Abstract][Full Text] [Related]
39. Neonatal Acute Lymphoblastic Leukemia with t(9;11) Translocation Presenting as Blueberry Muffin Baby: Successful Treatment by ALL-BFM Induction Therapy, Allogeneic Stem Cell Transplantation from an Unrelated Donor, and PCR-MRD-Guided Post-Transplant Follow-Up.
Schlegel S; Hamm H; Reichel A; Kneitz H; Ernestus K; Andres O; Wiegering VG; Eyrich M; Wölfl M; Schlegel PG
Am J Case Rep; 2020 Oct; 21():e927153. PubMed ID: 33106467
[TBL] [Abstract][Full Text] [Related]
40. Measurable residual disease of acute lymphoblastic leukemia in allograft settings: how to evaluate and intervene.
Sun YQ; Li SQ; Zhao XS; Chang YJ
Expert Rev Anticancer Ther; 2020 Jun; 20(6):453-464. PubMed ID: 32459519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
